Cinqair (reslizumab) - Merck (MSD), UCB, Teva
etokimab (ANB020) - AnaptysBio
Xolair (omalizumab) - Roche, Novartis
ASP0892 - Astellas
PVX108 - Aravax
Dupixent (dupilumab) - Sanofi, Regeneron
https://confit.atlas.jp/guide/event/jsawao2020/subject/G20079/category?cryptoId=
 
Alessandro Fiocchi
 
Aug 2, 2020
 
Prev